Home › Funds › Siren, L.L.C. › OLMA

Siren, L.L.C. position in OLMA

Olema Pharmaceuticals, Inc. · Health Care

Siren, L.L.C. reported holding 4,856,949 shares of OLMA (Olema Pharmaceuticals, Inc.) in its Q3 2026 13F filing — a position valued at US$42.0M, representing 1.00% of its reported portfolio and ranking #29 among its reported holdings. Siren, L.L.C. has disclosed OLMA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)4.86M sh
Reported value held$41.96M
Portfolio Weight1.00%
First reportedQ4 2025
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s OLMA position evolved

Siren, L.L.C. first disclosed a stake in OLMA in Q4 2025 at 3,300,700 shares (US$82.5M). Across 4 filings, Siren, L.L.C. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,856,949 shares valued at US$42.0M. Notable position changes include a 44% increase in Q1 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.30M $82.52M New
Q1 2026 4.76M $70.93M Add
Q2 2026 4.86M $60.76M Add
Q3 2026 4.86M $41.96M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OLMA and 13F data

OLMA (Olema Pharmaceuticals, Inc.) is a Health Care company. 41 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OLMA

All OLMA fund holders →

FAQ

How long has Siren, L.L.C. held OLMA?

Siren, L.L.C. has disclosed OLMA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Siren, L.L.C.'s current position in OLMA?

As of Q3 2026, Siren, L.L.C. holds 4.86M shares of OLMA (Olema Pharmaceuticals, Inc.), valued at $41.96M, representing 1.00% of its reported portfolio and ranking #29.

Has Siren, L.L.C. been buying or selling OLMA?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in OLMA.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.